Apr 17 |
FSD Pharma Expands Investigative Pipeline to Include Potential Weight Loss and Liver Health Formulations and Products
|
Apr 15 |
FSD Pharma Provides Update on its Investment in Celly Nutrition Corp., a Company Launching a Product that can assist in Expediting Alcohol Metabolism and Faster Recovery from Alcohol Consumption
|
Apr 8 |
FSD Pharma receives Nasdaq notification regarding minimum bid price deficiency
|
Apr 8 |
FSD Pharma Inc. Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
|
Apr 2 |
FSD Pharma GAAP EPS of -$0.46
|
Mar 30 |
Psychedelics Headlines: A Form Of Life, Treating Chronic Pain, Microdosing And More
|